Treatment with Human Mesenchymal Stem Cells (Remestemcel-L) Is Effective in Pediatric Patients with Refractory Acute Graft Versus Host Disease
Publication
, Conference
Kurtzberg, J; Prockop, SE; Prasad, VK; Chaudhury, S; Teira, P; Nemecek, E; Horn, B; Burke, E; Hayes, J; Skerrett, D
Published in: Biology of Blood and Marrow Transplantation
February 2015
Duke Scholars
Published In
Biology of Blood and Marrow Transplantation
DOI
ISSN
1083-8791
Publication Date
February 2015
Volume
21
Issue
2
Start / End Page
S338 / S339
Publisher
Elsevier BV
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Kurtzberg, J., Prockop, S. E., Prasad, V. K., Chaudhury, S., Teira, P., Nemecek, E., … Skerrett, D. (2015). Treatment with Human Mesenchymal Stem Cells (Remestemcel-L) Is Effective in Pediatric Patients with Refractory Acute Graft Versus Host Disease. In Biology of Blood and Marrow Transplantation (Vol. 21, pp. S338–S339). Elsevier BV. https://doi.org/10.1016/j.bbmt.2014.11.539
Kurtzberg, Joanne, Susan E. Prockop, Vinod K. Prasad, Sonali Chaudhury, Pierre Teira, Eneida Nemecek, Biljana Horn, Elizabeth Burke, Jack Hayes, and Donna Skerrett. “Treatment with Human Mesenchymal Stem Cells (Remestemcel-L) Is Effective in Pediatric Patients with Refractory Acute Graft Versus Host Disease.” In Biology of Blood and Marrow Transplantation, 21:S338–39. Elsevier BV, 2015. https://doi.org/10.1016/j.bbmt.2014.11.539.
Kurtzberg J, Prockop SE, Prasad VK, Chaudhury S, Teira P, Nemecek E, et al. Treatment with Human Mesenchymal Stem Cells (Remestemcel-L) Is Effective in Pediatric Patients with Refractory Acute Graft Versus Host Disease. In: Biology of Blood and Marrow Transplantation. Elsevier BV; 2015. p. S338–9.
Kurtzberg, Joanne, et al. “Treatment with Human Mesenchymal Stem Cells (Remestemcel-L) Is Effective in Pediatric Patients with Refractory Acute Graft Versus Host Disease.” Biology of Blood and Marrow Transplantation, vol. 21, no. 2, Elsevier BV, 2015, pp. S338–39. Crossref, doi:10.1016/j.bbmt.2014.11.539.
Kurtzberg J, Prockop SE, Prasad VK, Chaudhury S, Teira P, Nemecek E, Horn B, Burke E, Hayes J, Skerrett D. Treatment with Human Mesenchymal Stem Cells (Remestemcel-L) Is Effective in Pediatric Patients with Refractory Acute Graft Versus Host Disease. Biology of Blood and Marrow Transplantation. Elsevier BV; 2015. p. S338–S339.
Published In
Biology of Blood and Marrow Transplantation
DOI
ISSN
1083-8791
Publication Date
February 2015
Volume
21
Issue
2
Start / End Page
S338 / S339
Publisher
Elsevier BV
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences